Skip to main content
. 2019 Jun 3;6:77. doi: 10.3389/fnut.2019.00077

Table 3.

Energy intake, macronutrients, micronutrients, fiber dietary, and DII before and after therapy.

variables All (n = 45) Increased E-DII (n = 23) Decreased E-DII (n = 22) Effect size Observed power
Baseline After therapy Baseline After therapy Baseline After therapy
Energy Intake (kcal) 1965.49 ± 830.70 1491.40 ± 623.8a 1894.09 ± 901.66 1532.70 ± 639.21 2040.14 ± 763.37 1448.23 ± 619.22a 0.21 0.92
Carbohydrate (g) 251.92 ± 106.14 181.06 ± 67.14a 245.10 ± 120.69 180.88 ± 48.26a 259.39 ± 89.94 181.25 ± 83.69a 0.24 0.95
Protein (g) 97.11 ± 51.29 81.24 ± 57.8 94.36 ± 49.90 90.36 ± 76.14 99.99 ± 53.72 71.70 ± 27.22 0.04 0.31
Fat (g) 25.95 ± 45.70 14.22 ± 10.17a 60.37 ± 32.78 50.46 ± 44.21 70.14 ± 31.29 49.28 ± 33.93a 0.14 0.76
Saturated Fat (g) 30.12 ± 50.24 12.92 ± 8.16 16.87 ± 11.87 15.55 ± 10.01 35.46 ± 63.59 12.83 ± 10.40a 0.06 0.39
Polyunsaturated fat (g) 8.64 ± 6.08 6.09 ± 4.87a 8.70 ± 5.86 6.31 ± 5.87 8.58 ± 6.43 5.86 ± 3.69 0.09 0.53
Fiber (g) 19.68 ± 13.4 16.05 ± 7.99 23.03 ± 13.90 15.16 ± 8.00a 16.18 ± 12.18 16.99 ± 8.07 0.04 0.30
Dietary Cholesterol (mg) 287.18 ± 184.41 236.5 ± 185.32 270.87 ± 181.17 263.88 ± 209.76 304.23 ± 190.45 207.87 ± 155.51 0.05 0.32
Sodium (mg) 4172.73 ± 3491.2 2634.38 ± 2264.83a 4389.47 ± 3824.32 3205.96 ± 2690.59 4150.68 ± 3191.44 2036.83 ± 1559.32a 0.22 0.93
E-DII 1.16 ± 1.52 0.83 ± 1.49 0.24 ± 1.19 1.57 ± 1.31a 2.21 ± 1.20 0.06 ± 1.27a,c 0.11 0.66
Glycemic Load 82.58 ± 51.36 59.82 ± 35.72a 84.13 ± 56.98 58.52 ± 29.76a 80.95 ± 46.06 61.18 ± 41.74 0.13 0.70
Vitamin C (mg) 102.10 ± 106.84 112.68 ± 177.30 135.91 ± 112.90 54.59 ± 47.03a 66.75 ± 89.45 173.42 ± 236.61a,c 0.04 0.07
Vitamin E (mg) 10.25 ± 7.74 6.91 ± 6.72a 10.98 ± 7.83 5.84 ± 5.55a 9.49 ± 7.76 8.03 ± 7.73 0.10 0.57
Folate (mcg) 148.64 ± 92.25 108.66 ± 68.03a 171.58 ± 93.19 84.57 ± 42.83a 124.65 ± 133.85 133.85 ± 80.47c 0.12 0.67

E-DII, Energy- adjusted Dietary Inflammatory Index; a-P < 0.05;

a

statistic difference between baseline and after therapy of obese adolescents (p < 0.05);

b

statistic difference between baseline of adolescents (p < 0.05c) statistic difference between adolescents in the end of therapy;

c

statistic difference between the groups in the end of therapy.